Geode Capital Management
RVLP

Geode Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Geode Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-307,266
Closed -$26.6K – 4787
2023
Q3 		$26.6K Hold
307,266
– – ﹤0.01% 4568
2023
Q2 		$172K Hold
307,266
– – ﹤0.01% 4105
2023
Q1 		$350K Hold
307,266
– – ﹤0.01% 3789
2022
Q4 		$344K Buy
307,266
+2,884
+0.9% +$4.6K ﹤0.01% 3841
2022
Q3 		$639K Buy
304,382
+41,605
+16% +$80.8K ﹤0.01% 3597
2022
Q2 		$357K Buy
262,777
+9,692
+4% +$14K ﹤0.01% 3945
2022
Q1 		$427K Buy
253,085
+109,423
+76% +$156K ﹤0.01% 4018
2021
Q4 		$155K Sell
143,662
-2,770
-2% -$4.5K ﹤0.01% 4587
2021
Q3 		$431K Sell
146,432
-9,286
-6% -$31.2K ﹤0.01% 4101
2021
Q2 		$468K Sell
155,718
-85,013
-35% -$260K ﹤0.01% 3975
2021
Q1 		$784K Buy
240,731
+14,695
+7% +$60.4K ﹤0.01% 3656
2020
Q4 		$931K Buy
226,036
+7,101
+3% +$40.9K ﹤0.01% 3386
2020
Q3 		$1.18M Sell
218,935
-449
-0.2% -$2.59K ﹤0.01% 3141
2020
Q2 		$1.48M Buy
219,384
+15,400
+8% +$75.4K ﹤0.01% 3004
2020
Q1 		$648K Buy
203,984
+66,058
+48% +$352K ﹤0.01% 3189
2019
Q4 		$964K Buy
137,926
+32,740
+31% +$175K ﹤0.01% 3289
2019
Q3 		$403K Buy
105,186
+284
+0.3% +$962 ﹤0.01% 3543
2019
Q2 		$398K Buy
104,902
+12,593
+14% +$41.9K ﹤0.01% 3551
2019
Q1 		$332K Buy
92,309
+5,993
+7% +$44.1K ﹤0.01% 3582
2018
Q4 		$668K Buy
+86,316
New +$691K ﹤0.01% 3261

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Geode Capital Management's RVLP Position: Q4 2023 in Review

Geode Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 307,266 shares — an estimated $26.6K sold.

Geode Capital Management first reported a position in RVLP in Q4 2018 and held it in 20 quarters. The position peaked at $1.48M in Q2 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Geode Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 307,266 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $26.6K.
  • Geode Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • Geode Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.48M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.